Data Translator: an Open Science Data Platform for Mechanistic Disease Discovery

17. Sep 2017
Data Translator: an Open Science Data Platform for Mechanistic Disease Discovery
Data Translator: an Open Science Data Platform for Mechanistic Disease Discovery
Data Translator: an Open Science Data Platform for Mechanistic Disease Discovery
Data Translator: an Open Science Data Platform for Mechanistic Disease Discovery
Data Translator: an Open Science Data Platform for Mechanistic Disease Discovery
Data Translator: an Open Science Data Platform for Mechanistic Disease Discovery
Data Translator: an Open Science Data Platform for Mechanistic Disease Discovery
Data Translator: an Open Science Data Platform for Mechanistic Disease Discovery
Data Translator: an Open Science Data Platform for Mechanistic Disease Discovery
Data Translator: an Open Science Data Platform for Mechanistic Disease Discovery
Data Translator: an Open Science Data Platform for Mechanistic Disease Discovery
Data Translator: an Open Science Data Platform for Mechanistic Disease Discovery
Data Translator: an Open Science Data Platform for Mechanistic Disease Discovery
Data Translator: an Open Science Data Platform for Mechanistic Disease Discovery
Data Translator: an Open Science Data Platform for Mechanistic Disease Discovery
Data Translator: an Open Science Data Platform for Mechanistic Disease Discovery
Data Translator: an Open Science Data Platform for Mechanistic Disease Discovery
Data Translator: an Open Science Data Platform for Mechanistic Disease Discovery
Data Translator: an Open Science Data Platform for Mechanistic Disease Discovery
Data Translator: an Open Science Data Platform for Mechanistic Disease Discovery
Data Translator: an Open Science Data Platform for Mechanistic Disease Discovery
Data Translator: an Open Science Data Platform for Mechanistic Disease Discovery
Data Translator: an Open Science Data Platform for Mechanistic Disease Discovery
Data Translator: an Open Science Data Platform for Mechanistic Disease Discovery
Data Translator: an Open Science Data Platform for Mechanistic Disease Discovery
Data Translator: an Open Science Data Platform for Mechanistic Disease Discovery
1 von 26

Más contenido relacionado

Was ist angesagt?

Deep phenotyping for everyoneDeep phenotyping for everyone
Deep phenotyping for everyonemhaendel
The Monarch Initiative: A semantic phenomics approach to disease discoveryThe Monarch Initiative: A semantic phenomics approach to disease discovery
The Monarch Initiative: A semantic phenomics approach to disease discoverymhaendel
Phenopackets as applied to variant interpretation Phenopackets as applied to variant interpretation
Phenopackets as applied to variant interpretation mhaendel
Why the world needs phenopacketeers, and how to be oneWhy the world needs phenopacketeers, and how to be one
Why the world needs phenopacketeers, and how to be onemhaendel
Semantic phenotyping for disease diagnosis and discovery Semantic phenotyping for disease diagnosis and discovery
Semantic phenotyping for disease diagnosis and discovery mhaendel
On the frontier of genotype-2-phenotype data integrationOn the frontier of genotype-2-phenotype data integration
On the frontier of genotype-2-phenotype data integrationmhaendel

Was ist angesagt?(20)

Similar a Data Translator: an Open Science Data Platform for Mechanistic Disease Discovery

Standards for public health genomic epidemiology - Biocuration 2015Standards for public health genomic epidemiology - Biocuration 2015
Standards for public health genomic epidemiology - Biocuration 2015Melanie Courtot
REFRACT Lima 2019REFRACT Lima 2019
REFRACT Lima 2019Fanny Casado, Ph.D.
Indications discovery and drug repurposingIndications discovery and drug repurposing
Indications discovery and drug repurposingSean Ekins
petros tsipouraspetros tsipouras
petros tsipourasTHCwIT Conference
Mel Reichman on Pool Shark’s Cues for More Efficient Drug DiscoveryMel Reichman on Pool Shark’s Cues for More Efficient Drug Discovery
Mel Reichman on Pool Shark’s Cues for More Efficient Drug DiscoveryJean-Claude Bradley
A systematic approach to Genotype-Phenotype correlationsA systematic approach to Genotype-Phenotype correlations
A systematic approach to Genotype-Phenotype correlationsfisherp

Similar a Data Translator: an Open Science Data Platform for Mechanistic Disease Discovery(20)

Más de mhaendel

The Software and Data Licensing Solution: Not Your Dad’s UBMTA The Software and Data Licensing Solution: Not Your Dad’s UBMTA
The Software and Data Licensing Solution: Not Your Dad’s UBMTA mhaendel
Equivalence is in the (ID) of the beholderEquivalence is in the (ID) of the beholder
Equivalence is in the (ID) of the beholdermhaendel
Building (and traveling) the data-brick road:  A report from the front lines ...Building (and traveling) the data-brick road:  A report from the front lines ...
Building (and traveling) the data-brick road: A report from the front lines ...mhaendel
Reusable data for biomedicine:  A data licensing odysseyReusable data for biomedicine:  A data licensing odyssey
Reusable data for biomedicine: A data licensing odysseymhaendel
How open is open?  An evaluation rubric for public knowledgebasesHow open is open?  An evaluation rubric for public knowledgebases
How open is open? An evaluation rubric for public knowledgebasesmhaendel
Science in the open, what does it take?Science in the open, what does it take?
Science in the open, what does it take?mhaendel

Último

infographic-01.pdfinfographic-01.pdf
infographic-01.pdfRevitalizeOgranicSto
Chương 3. Tài liệu EU GMP.pdfChương 3. Tài liệu EU GMP.pdf
Chương 3. Tài liệu EU GMP.pdfCông ty cổ phần GMPc Việt Nam | Tư vấn GMP, HS GMP, CGMP ASEAN, EU GMP, WHO GMP
ROJoson PEP Talk: Two Early Detection Programs for CancersROJoson PEP Talk: Two Early Detection Programs for Cancers
ROJoson PEP Talk: Two Early Detection Programs for CancersReynaldo Joson
duty roster in nursing.pptxduty roster in nursing.pptx
duty roster in nursing.pptxManeera Gulzar
Endometriosis and Subfertility - What to do?Endometriosis and Subfertility - What to do?
Endometriosis and Subfertility - What to do?Sujoy Dasgupta
ROJoson PEP Talk: Epidermal Cysts in SkinROJoson PEP Talk: Epidermal Cysts in Skin
ROJoson PEP Talk: Epidermal Cysts in SkinReynaldo Joson

Data Translator: an Open Science Data Platform for Mechanistic Disease Discovery

Hinweis der Redaktion

  1. Geospatial social determinants of health
  2. Geospatial social determinants of health
  3. If clinvar + omim 20  80%
  4. If clinvar + omim 20  80%
  5. If clinvar + omim 20  80%
  6. 2 issues: database integration, vocabulary integration
  7. Multiple databases
  8. Our approach is to try and get the machine to understand the terms so that it can assist us intelligently.
  9. We make things digestible. Complex concepts into simpler parts. We use ontologies that are comparative by design.
  10. This was the novel case we solved. The UDP patient had a number of signs and symptoms including various platelet abnormalities. The same heterozygous, missense mutation was seen in 2 patients and ranked top by Exomiser. It had never been seen in any of the SNP databases and was predicted maximally pathogenic. Finally a mouse curated by MGI involving a heterozygous, missense point mutation introduced by chemical mutagenesis exhibited strikingly similar platelet abnormalities. In thefirst 1936 patients, 82% are in the top 5 Exomiser hits. This is across a whole range of different rare diseases and family structures ie. 34% cases are just simple singletons.
  11. This was the novel case we solved. The UDP patient had a number of signs and symptoms including various platelet abnormalities. The same heterozygous, missense mutation was seen in 2 patients and ranked top by Exomiser. It had never been seen in any of the SNP databases and was predicted maximally pathogenic. Finally a mouse curated by MGI involving a heterozygous, missense point mutation introduced by chemical mutagenesis exhibited strikingly similar platelet abnormalities. In thefirst 1936 patients, 82% are in the top 5 Exomiser hits. This is across a whole range of different rare diseases and family structures ie. 34% cases are just simple singletons.
  12. If we include bridging ontologies, we can unify diseases across sources AND phenotypes across sources and organisms.
  13. If we include bridging ontologies, we can unify diseases across sources AND phenotypes across sources and organisms.
  14. There are a lot of people who have contributed to this work over many years. 
  15. Fully translational – from bench to bedside – group of stakeholders, contributors and partners
  16. The classic G+E=P. But the = has a lot that can be applied to aid the linking.
  17. Phenopackets for clinicians
  18. Phenopackets to assist patient data sharing.